Back to trial details

Intake questionnaire

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Applying to NEXT Houston · Houston, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced or Metastatic Solid Tumors?
3. Are you able to travel to Houston for study visits?